RedixFi
Pre-openNIFTY24,536.6+2.4%
Market feed live

MANIPALHOS · Manipal Health Enterprises Ltd · Healthcare Facilities

MANIPALHOS · Manipal Health Enterprises Ltd · Healthcare Facilities

₹657.25-1.5%

As of 05 Nov close

52-week range. Price history incomplete · as of 05 Nov 2026

Price chartDaily closes on the stock page.

Stock Condition:Pro

Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.

Full signal detail →

Fundamentals as of 16 Oct 2026

Debt-to-equity above 1x

Revenue (latest Q)

₹3,091 Cr

Revenue YoY

PAT YoY

-7.5%

Operating margin

Revenue, last 4 quarters

Source: Yahoo Finance, as of 30 Jun 2026

P/E (TTM)

P/B

8.9

P/S (TTM)

7.6

Sector P/E

29

Dividend yield

0.0%

Source: Yahoo Finance, as of 29 Oct 2026

CompanyP/EP/BNet marginROED/EDiv. yield
MANIPALHOS (this stock)1328.9+7.8%Not available from data source1.530.0%
Apollo Hospitals Enterprise65.313.5Not available from data sourceNot available from data sourceNot available from data sourceNot available from data source
Max Healthcare Institute67.69.3Not available from data sourceNot available from data sourceNot available from data sourceNot available from data source
Aster DM Healthcare *126.915.5+6.5%+7.0%0.49+0.4%

* Net margin, ROE, D/E and dividend yield for these companies come from RedixFi fundamentals; the data vendor had no values for them.

Promoter

stable

FII

stable

MF

3.53%

stable

Insider trades

No insider trades in the last 12 months.

Bulk/block deals

No bulk/block deals in the last 12 months.

News timeline

No related news.

Concalls & investor presentations

AI-generated
Concall transcriptPositive27 Aug 2026
View source filing →

Key takeaway: Manipal Health Enterprises Limited reported Q1 FY27 revenue of INR3,091 crores, a 38% year-on-year growth, with network EBITDA of INR749 crores, up 26% YoY. Excluding a one-off gain, EBITDA growth was over 30%. Operating margins stood at 25% (excluding Sahyadri) and 24.2% including Sahyadri. Inpatient volumes rose 39%, OP volumes 26%, and average occupancy increased 290 bps to 65%. Digital revenue contributed INR710 crores (23% of total revenue). Sahyadri Hospitals reported revenue growth of 13% and EBITDA growth of 19%, with ARPOB at INR45,000/day and occupancy at 63%. The company added 103 beds in Nashik and launched its 50th hospital in Bangalore, adding 300 beds. A Kinder Hospital acquisition in Whitefield added 100 beds. Management emphasized volume-led growth, operational efficiency, and integration of Sahyadri into the Manipal network over 18 months. Greenfield hospitals in Bengaluru, Raipur, and Mumbai are expected to drive future growth, with capex of INR4,000 crores planned over 3-4 years. Net debt-to-EBITDA is projected to reduce to 0.9x post-IPO. The company aims to expand into Kerala, NCR, and Hyderabad through inorganic opportunities.

The document highlights strong revenue and EBITDA growth, operational improvements, and strategic expansions, with management expressing confidence in future growth drivers.

Sourced from an exchange-filed transcript, dated 27 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.

Governance disclosures

AI-generated

No governance disclosures identified in MANIPALHOS's filed documents yet.

Open full Signal Dashboard →